EP0746365A4
(en)
*
|
1993-09-14 |
1997-05-21 |
North Shore Lab Pty Ltd |
INJECTION DEVICE
|
CA2551185C
(en)
*
|
1994-03-28 |
2007-10-30 |
Sdgi Holdings, Inc. |
Apparatus and method for anterior spinal stabilization
|
SE9403433D0
(sv)
|
1994-10-10 |
1994-10-10 |
Pharmacia Ab |
Injection device
|
SE9502285D0
(sv)
*
|
1995-06-22 |
1995-06-22 |
Pharmacia Ab |
Improvements related to injections
|
US6058321A
(en)
*
|
1995-09-07 |
2000-05-02 |
Swayze; Claude R. |
Instrument for continuously monitoring fetal heart rate and intermittently monitoring fetal blood pH and method of use
|
WO1997036625A1
(de)
|
1996-04-02 |
1997-10-09 |
Disetronic Licensing Ag |
Injektionsgerät
|
DK0828527T3
(da)
*
|
1996-04-02 |
2002-11-25 |
Disetronic Licensing Ag |
Injektionsapparat
|
DE59610766D1
(de)
|
1996-07-05 |
2003-11-13 |
Disetronic Licensing Ag |
Injektionsgerät zum injizieren von flüssigkeit
|
EP0848624B1
(de)
*
|
1996-07-05 |
2005-10-26 |
Tecpharma Licensing AG |
Injektionsgerät zum injizieren von flüssigkeit
|
DE19717107B4
(de)
|
1997-04-23 |
2005-06-23 |
Disetronic Licensing Ag |
System aus Behältnis und Antriebsvorrichtung für einen Kolben, der in dem ein Medikamentfluid enthaltenden Behältnis gehalten ist
|
DE69841773D1
(de)
|
1997-04-24 |
2010-09-02 |
Nippon Telegraph & Telephone |
Mobiles kommunikationsverfahren und anordnung
|
DE19740187C1
(de)
*
|
1997-09-12 |
1999-04-15 |
Disetronic Licensing Ag |
Vorrichtung zur dosierten Ausschüttung eines injizierbaren Produkts
|
EP1032444B1
(de)
|
1997-11-17 |
2004-05-19 |
Tecpharma Licensing AG |
Nadelpenetrationsvorrichtung
|
DE59811344D1
(de)
|
1997-11-19 |
2004-06-09 |
B D Medico S A R L |
Nadelanordnung
|
US6482176B1
(en)
|
1997-11-27 |
2002-11-19 |
Disetronic Licensing Ag |
Method and device for controlling the introduction depth of an injection needle
|
DE19755125B4
(de)
*
|
1997-12-11 |
2006-04-20 |
Tecpharma Licensing Ag |
Nadelschutzvorrichtung für Injektionsgeräte
|
DK1047343T3
(da)
*
|
1998-01-12 |
2004-11-01 |
Alsensa Aps |
En injektor
|
US6949111B2
(en)
|
1998-02-13 |
2005-09-27 |
Steven Schraga |
Lancet device
|
US5997509A
(en)
|
1998-03-06 |
1999-12-07 |
Cornell Research Foundation, Inc. |
Minimally invasive gene therapy delivery device and method
|
CA2229522A1
(en)
|
1998-04-15 |
1999-10-15 |
Thomas Randall Inkpen |
Needle aid
|
DE19822031C2
(de)
|
1998-05-15 |
2000-03-23 |
Disetronic Licensing Ag |
Autoinjektionsgerät
|
DE19821933C1
(de)
|
1998-05-15 |
1999-11-11 |
Disetronic Licensing Ag |
Vorrichtung zur Verabreichung eines injizierbaren Produkts
|
US6290679B1
(en)
|
1999-05-14 |
2001-09-18 |
Disetronic Licensing Ag |
Device for metered administration of an injectable product
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
DE19925904C1
(de)
|
1999-06-07 |
2001-02-01 |
Disetronic Licensing Ag |
Vorrichtung zur subkutanen Verabreichung eines injizierbaren Produkts
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US8465468B1
(en)
|
2000-06-29 |
2013-06-18 |
Becton, Dickinson And Company |
Intradermal delivery of substances
|
US20020156453A1
(en)
*
|
1999-10-14 |
2002-10-24 |
Pettis Ronald J. |
Method and device for reducing therapeutic dosage
|
US20020095134A1
(en)
*
|
1999-10-14 |
2002-07-18 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US6776776B2
(en)
*
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US6843781B2
(en)
*
|
1999-10-14 |
2005-01-18 |
Becton, Dickinson And Company |
Intradermal needle
|
US6494865B1
(en)
*
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US7241275B2
(en)
*
|
1999-10-14 |
2007-07-10 |
Becton, Dickinson And Company |
Intradermal needle
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US8814896B2
(en)
|
1999-11-02 |
2014-08-26 |
Stat Medical Devices, Inc. |
Single use lancet assembly
|
US20050070945A1
(en)
*
|
1999-11-02 |
2005-03-31 |
Steven Schraga |
Single use lancet assembly
|
US6322575B1
(en)
|
2000-01-05 |
2001-11-27 |
Steven Schraga |
Lancet depth adjustment assembly
|
DE20006251U1
(de)
*
|
2000-04-05 |
2001-08-16 |
B D Medico Gmbh Mies |
Nadelschutzanordnung
|
US6508802B1
(en)
|
2000-05-23 |
2003-01-21 |
Cornell Research Foundation, Inc. |
Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart
|
US6547764B2
(en)
|
2000-05-31 |
2003-04-15 |
Novo Nordisk A/S |
Double pointed injection needle
|
US20040175360A1
(en)
*
|
2000-06-29 |
2004-09-09 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US20050008683A1
(en)
*
|
2000-06-29 |
2005-01-13 |
Becton Dickinson And Company |
Method for delivering interferons to the intradermal compartment
|
EP1313520B1
(en)
|
2000-08-02 |
2016-08-31 |
Becton Dickinson and Company |
Pen needle and safety shield system
|
US6986760B2
(en)
*
|
2000-08-02 |
2006-01-17 |
Becton, Dickinson And Company |
Pen needle and safety shield system
|
DE10044383C2
(de)
*
|
2000-09-08 |
2003-02-06 |
Disetronic Licensing Ag |
Nadelschutzvorrichtung
|
WO2002067983A1
(en)
*
|
2001-02-23 |
2002-09-06 |
Glaxosmithkline Biologicals S.A. |
Novel vaccine
|
AU2002254901A1
(en)
|
2001-02-23 |
2002-10-03 |
Smithkline Beecham Biologicals S.A. |
Influenza vaccine formulations for intradermal delivery
|
WO2002076374A1
(en)
|
2001-03-27 |
2002-10-03 |
Eli Lilly And Company |
Kit including side firing syringe needle for preparing a drug in an injection pen cartridge
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
ES2683629T3
(es)
*
|
2001-04-13 |
2018-09-27 |
Becton, Dickinson And Company |
Dispositivo de administración intradérmica de llenado previo con aguja oculta y protección pasiva
|
EP1381423A1
(en)
*
|
2001-04-13 |
2004-01-21 |
Becton, Dickinson and Company |
Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption
|
JP2004520144A
(ja)
*
|
2001-04-27 |
2004-07-08 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
新規ワクチン
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
MY134424A
(en)
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
AU2002310432A1
(en)
|
2001-06-13 |
2003-06-23 |
Steven Schraga |
Single use lancet device
|
US20050010193A1
(en)
*
|
2002-05-06 |
2005-01-13 |
Laurent Philippe E. |
Novel methods for administration of drugs and devices useful thereof
|
US20060018877A1
(en)
*
|
2001-06-29 |
2006-01-26 |
Mikszta John A |
Intradermal delivery of vacccines and therapeutic agents
|
US20030073609A1
(en)
*
|
2001-06-29 |
2003-04-17 |
Pinkerton Thomas C. |
Enhanced pharmacokinetic profile of intradermally delivered substances
|
BR0210628A
(pt)
*
|
2001-06-29 |
2004-08-10 |
Becton Dickinson Co |
Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula
|
US6918918B1
(en)
|
2001-08-14 |
2005-07-19 |
Steven Schraga |
Single use lancet assembly
|
US8048097B2
(en)
*
|
2001-08-14 |
2011-11-01 |
Steven Schraga |
Single use lancet assembly
|
US20040120964A1
(en)
*
|
2001-10-29 |
2004-06-24 |
Mikszta John A. |
Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
|
JP4603262B2
(ja)
*
|
2001-11-30 |
2010-12-22 |
ノボ・ノルデイスク・エー/エス |
安全な注射針構造
|
US20050033230A1
(en)
*
|
2002-02-15 |
2005-02-10 |
Alchas Paul G. |
Prefillable intradermal delivery device with hidden needle and passive shielding
|
DE10207276A1
(de)
*
|
2002-02-21 |
2003-09-11 |
Disetronic Licensing Ag |
Nadel-Insertionsvorrichtung mit quer bewegbarem Halteelement
|
CH695758A5
(de)
*
|
2002-03-05 |
2006-08-31 |
Tecpharma Licensing Ag |
Kühlvorrichtung für Injektionsgeräte.
|
US20040039407A1
(en)
*
|
2002-04-29 |
2004-02-26 |
Steven Schraga |
Lancet device
|
US8715309B2
(en)
|
2002-04-29 |
2014-05-06 |
Steven Schraga |
Lancet device
|
CA2484265C
(en)
*
|
2002-05-06 |
2012-08-07 |
Becton, Dickinson And Company |
Method and device for controlling drug pharmacokinetics
|
US20060264886A9
(en)
*
|
2002-05-06 |
2006-11-23 |
Pettis Ronald J |
Method for altering insulin pharmacokinetics
|
CA2497086A1
(en)
*
|
2002-08-30 |
2004-03-11 |
Becton, Dickinson And Company |
Method of controlling pharmacokinetics of immunomodulatory compounds
|
US8267890B2
(en)
|
2003-01-30 |
2012-09-18 |
Becton, Dickinson And Company |
Intradermal delivery device with contoured skin engaging surface geometry
|
WO2005026375A2
(en)
|
2003-05-22 |
2005-03-24 |
Fraunhofer Usa, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
BRPI0411428A
(pt)
*
|
2003-06-13 |
2006-07-25 |
Becton Dickinson Co |
distribuição intradérmica de agentes biologicamente ativos
|
US8932264B2
(en)
*
|
2003-08-11 |
2015-01-13 |
Becton, Dickinson And Company |
Medication delivery pen assembly with needle locking safety shield
|
US20050180952A1
(en)
*
|
2003-08-26 |
2005-08-18 |
Pettis Ronald J. |
Methods for intradermal delivery of therapeutics agents
|
JP3100042U
(ja)
*
|
2003-08-26 |
2004-04-30 |
アルプス電気株式会社 |
テレビジョンチューナ
|
JP4746545B2
(ja)
|
2003-08-28 |
2011-08-10 |
ベクトン・ディキンソン・アンド・カンパニー |
皮内注射装置
|
WO2005034949A1
(en)
*
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
FR2861284B1
(fr)
*
|
2003-10-24 |
2005-12-30 |
Gaetan Terrasse |
Dispositif d'inoculation therapeutique et diagnostique
|
WO2005091922A2
(en)
*
|
2004-03-03 |
2005-10-06 |
Becton, Dickinson And Company |
Methods and devices for improving delivery of a substance to skin
|
WO2005115360A2
(en)
*
|
2004-05-11 |
2005-12-08 |
Becton, Dickinson And Company |
Formulations of anti-pain agents and methods of using the same
|
WO2007001448A2
(en)
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US20060178686A1
(en)
*
|
2005-02-07 |
2006-08-10 |
Steven Schraga |
Single use lancet device
|
WO2006100110A1
(en)
|
2005-03-23 |
2006-09-28 |
Glaxosmithkline Biologicals S.A. |
Novel composition
|
MX2007012226A
(es)
|
2005-04-04 |
2007-12-10 |
Univ Florida |
Analogos de polieter de desferritiocina.
|
WO2007117264A2
(en)
*
|
2005-08-03 |
2007-10-18 |
Fraunhofer Usa, Inc. |
Compositions and methods for production of immunoglobulins
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
WO2007070682A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
WO2007095320A2
(en)
*
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Hpv antigens, vaccine compositions, and related methods
|
WO2008048344A2
(en)
*
|
2006-02-13 |
2008-04-24 |
Fraunhofer Usa, Inc. |
Bacillus anthracis antigens, vaccine compositions, and related methods
|
US8124103B2
(en)
*
|
2006-02-13 |
2012-02-28 |
Fraunhofer Usa, Inc |
Influenza antigens, vaccine compositions, and related methods
|
WO2007106415A2
(en)
*
|
2006-03-10 |
2007-09-20 |
Massachusetts Institute Of Technology |
Triggered self-assembly conjugates and nanosystems
|
CA2681668C
(en)
|
2006-03-23 |
2014-04-01 |
Michael S. Singer |
Compositions comprising prostaglandin f2-alpha analogs and methods for reducing body fat
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
US20090325944A1
(en)
*
|
2006-04-12 |
2009-12-31 |
Suzanne Walker Kahne |
Methods and Compositions for Modulating Glycosylation
|
CA2652280C
(en)
|
2006-05-15 |
2014-01-28 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
EP2492684B1
(en)
|
2006-06-02 |
2016-12-28 |
President and Fellows of Harvard College |
Protein surface remodeling
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
PL2422810T3
(pl)
|
2006-07-17 |
2015-03-31 |
Glaxosmithkline Biologicals Sa |
Szczepionka przeciw grypie
|
WO2008021367A2
(en)
*
|
2006-08-11 |
2008-02-21 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
JP2010500880A
(ja)
*
|
2006-08-14 |
2010-01-14 |
マサチューセッツ・インスティテュート・オブ・テクノロジー |
ヘマグルチニンポリペプチド、ならびにヘマグルチニンポリペプチドに関連する試薬および方法
|
US20090269342A1
(en)
*
|
2006-08-14 |
2009-10-29 |
Massachusetts Institute Of Technology |
Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
|
JO3598B1
(ar)
*
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
US7811254B2
(en)
*
|
2006-10-18 |
2010-10-12 |
Meridian Medical Technologies, Inc. |
Autoinjector with needle depth adapter
|
KR20090106493A
(ko)
|
2006-12-01 |
2009-10-09 |
안테리오스, 인코퍼레이티드 |
양쪽성 엔티티 나노입자
|
AU2007333225B2
(en)
*
|
2006-12-08 |
2014-06-12 |
Massachusetts Institute Of Technology |
Delivery of nanoparticles and/or agents to cells
|
CA2984226C
(en)
|
2006-12-26 |
2021-02-23 |
Lantheus Medical Imaging, Inc. |
Ligands for imaging cardiac innervation
|
US8889632B2
(en)
|
2007-01-31 |
2014-11-18 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
EP2134830A2
(en)
*
|
2007-02-09 |
2009-12-23 |
Massachusetts Institute of Technology |
Oscillating cell culture bioreactor
|
EP2137170B1
(en)
|
2007-03-15 |
2016-03-09 |
University of Florida Research Foundation, Inc. |
Desferrithiocin polyether analogues
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
CN101730708B
(zh)
|
2007-03-28 |
2013-09-18 |
哈佛大学校长及研究员协会 |
缝合多肽
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
WO2008124639A2
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
WO2008134643A2
(en)
*
|
2007-04-28 |
2008-11-06 |
Fraunhofer Usa, Inc. |
Trypanosoma antigens, vaccine compositions, and related methods
|
AU2008263970B2
(en)
*
|
2007-06-14 |
2014-01-30 |
Crucell Switzerland Ag |
Intradermal influenza vaccine
|
US8524444B2
(en)
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
CA2692933C
(en)
|
2007-07-11 |
2016-10-18 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
CN101820903A
(zh)
*
|
2007-08-20 |
2010-09-01 |
美国弗劳恩霍夫股份有限公司 |
预防性和治疗性流感疫苗、抗原、组合物和方法
|
US8604004B2
(en)
*
|
2007-10-04 |
2013-12-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
ES2627292T3
(es)
|
2007-10-12 |
2017-07-27 |
Massachusetts Institute Of Technology |
Nanotecnología de vacunas
|
AU2009204345A1
(en)
*
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
US8632503B2
(en)
|
2008-03-13 |
2014-01-21 |
Becton, Dickinson And Company |
Safety pen needle assembly having shielding for patient and non-patient ends
|
ES2729650T3
(es)
|
2008-03-13 |
2019-11-05 |
Becton Dickinson Co |
Conjunto de aguja de seguridad
|
EP2262559B1
(en)
|
2008-03-13 |
2019-05-01 |
Becton, Dickinson and Company |
Safety pen needle assembly having shield for non-patient end
|
TW201000107A
(en)
*
|
2008-04-09 |
2010-01-01 |
Infinity Pharmaceuticals Inc |
Inhibitors of fatty acid amide hydrolase
|
JP2011523353A
(ja)
*
|
2008-04-28 |
2011-08-11 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
細胞透過のための過剰に荷電されたタンパク質
|
MX2010013562A
(es)
|
2008-06-26 |
2011-02-15 |
Anterios Inc |
Aplicacion dermica.
|
WO2010009271A2
(en)
|
2008-07-15 |
2010-01-21 |
Academia Sinica |
Glycan arrays on ptfe-like aluminum coated glass slides and related methods
|
WO2010011313A2
(en)
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
CA2734991A1
(en)
*
|
2008-07-23 |
2010-01-28 |
Massachusetts Institute Of Technology |
Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
|
US8734803B2
(en)
|
2008-09-28 |
2014-05-27 |
Ibio Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8277812B2
(en)
*
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US9637746B2
(en)
|
2008-12-15 |
2017-05-02 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways
|
US20110008867A1
(en)
*
|
2008-12-22 |
2011-01-13 |
Greenlight Biosciences |
Compositions and methods for the production of a compound
|
US8546564B2
(en)
|
2009-04-07 |
2013-10-01 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
WO2010118159A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
EP2424877A4
(en)
|
2009-04-28 |
2013-01-02 |
Harvard College |
SUPERCHARGED PROTEINS FOR CELL PENETRATION
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8957075B2
(en)
|
2009-06-01 |
2015-02-17 |
President And Fellows Of Harvard College |
O-GlcNAc transferase inhibitors and uses thereof
|
CN102510755A
(zh)
|
2009-07-13 |
2012-06-20 |
哈佛大学校长及研究员协会 |
双功能钉接多肽和其用途
|
CA2774973A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
WO2011041391A1
(en)
|
2009-09-29 |
2011-04-07 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
CA2784807C
(en)
|
2009-12-29 |
2021-12-14 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
EP2528615B1
(en)
|
2010-01-27 |
2020-05-13 |
Massachusetts Institute of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
KR101888026B1
(ko)
|
2010-02-03 |
2018-08-13 |
인피니티 파마슈티컬스, 인코포레이티드 |
지방산 아미드 하이드롤라제 저해제
|
JP5827962B2
(ja)
|
2010-03-08 |
2015-12-02 |
スローン ケタリング インスティテュート フォア キャンサー リサーチ |
Cdc7キナーゼ阻害剤およびその使用
|
EP2550285B1
(en)
|
2010-03-22 |
2017-07-19 |
President and Fellows of Harvard College |
Trioxacarcins and uses thereof
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
EP2566853B1
(en)
|
2010-05-05 |
2017-01-25 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
US8956833B2
(en)
|
2010-05-07 |
2015-02-17 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through enzyme relocation
|
KR102136503B1
(ko)
|
2010-05-11 |
2020-07-21 |
랜티우스 메디컬 이메징, 인크. |
영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
|
WO2011160042A2
(en)
|
2010-06-18 |
2011-12-22 |
Makoto Life Sciences, Inc. |
Prpk-tprkb modulators and uses thereof
|
EP2399631A1
(en)
*
|
2010-06-28 |
2011-12-28 |
Sanofi-Aventis Deutschland GmbH |
Auto-injector with injection damper
|
EP3578205A1
(en)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
CA2807685C
(en)
|
2010-08-13 |
2020-10-06 |
Aileron Therapeutics, Inc. |
P53 derived peptidomimetic macrocycle
|
EP2611922A1
(en)
|
2010-08-31 |
2013-07-10 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
CA2811023A1
(en)
|
2010-09-21 |
2012-03-29 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
CA2813466A1
(en)
|
2010-10-01 |
2012-04-05 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids that disrupt major groove binding partner interactions
|
CA2813078A1
(en)
|
2010-10-04 |
2012-04-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
EP2637699B1
(en)
*
|
2010-11-09 |
2018-05-16 |
Novo Nordisk A/S |
Double-acylated glp-1 derivatives with a linker
|
EP2637669A4
(en)
|
2010-11-10 |
2014-04-02 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and their use
|
CA2824197C
(en)
|
2011-01-10 |
2020-02-25 |
Michael Martin |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
ES2687494T3
(es)
|
2011-01-19 |
2018-10-25 |
Topokine Therapeutics, Inc. |
Métodos y composiciones para reducir la grasa corporal
|
JP2014503586A
(ja)
|
2011-01-24 |
2014-02-13 |
アンテリオス, インコーポレイテッド |
油組成物
|
AU2012209274A1
(en)
|
2011-01-24 |
2013-09-12 |
Anterios, Inc. |
Nanoparticle compositions, formulations thereof, and uses therefor
|
KR20140003572A
(ko)
|
2011-01-24 |
2014-01-09 |
안테리오스, 인코퍼레이티드 |
나노입자 조성물
|
EP2680837A4
(en)
|
2011-03-03 |
2015-06-03 |
Tersus Pharmaceuticals Llc |
COMPOSITIONS AND METHODS COMPRISING C16: 1N7-PALMITOLATE
|
US9193767B2
(en)
|
2011-03-30 |
2015-11-24 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
JP6061922B2
(ja)
|
2011-06-22 |
2017-01-18 |
ザ ジェネラル ホスピタル コーポレイション |
プロテイノパチーの処置方法
|
CA2842190A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
EP3483150A1
(en)
|
2011-07-22 |
2019-05-15 |
Massachusetts Institute Of Technology |
Activators of class 1 histone deacetylases (hdacs) and uses thereof
|
RU2014111823A
(ru)
|
2011-08-29 |
2015-10-10 |
Инфинити Фармасьютикалз, Инк. |
Гетероциклические соединения и их применения
|
EP2753702B1
(en)
|
2011-09-09 |
2021-12-15 |
GreenLight Biosciences, Inc. |
Cell-free preparation of carbapenems
|
ES2731471T3
(es)
|
2011-09-09 |
2019-11-15 |
Lantheus Medical Imaging Inc |
Composiciones, métodos y sistemas para la síntesis y el uso de agentes de obtención de imágenes
|
EP2755693A4
(en)
|
2011-09-12 |
2015-05-20 |
Moderna Therapeutics Inc |
MODIFIED NUCLEIC ACIDS AND METHODS OF USE
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
CN110511939A
(zh)
|
2011-10-03 |
2019-11-29 |
现代泰克斯公司 |
修饰的核苷、核苷酸和核酸及其用途
|
US9096684B2
(en)
|
2011-10-18 |
2015-08-04 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
WO2013074986A1
(en)
|
2011-11-17 |
2013-05-23 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP2791160B1
(en)
|
2011-12-16 |
2022-03-02 |
ModernaTX, Inc. |
Modified mrna compositions
|
AU2012352025B2
(en)
|
2011-12-16 |
2018-01-18 |
University Of Florida Research Foundation, Inc. |
Uses of 4'-desferrithiocin analogs
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
WO2013123266A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
JP6450192B2
(ja)
|
2012-02-15 |
2019-01-09 |
エイルロン セラピューティクス,インコーポレイテッド |
トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物
|
US9902985B2
(en)
|
2012-04-06 |
2018-02-27 |
President And Fellows Of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
WO2013152277A2
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
WO2013151697A1
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
EP2841098A4
(en)
|
2012-04-23 |
2016-03-02 |
Allertein Therapeutics Llc |
NANOPARTICLES FOR THE TREATMENT OF ALLERGIES
|
CN109265541A
(zh)
|
2012-05-10 |
2019-01-25 |
麻省理工学院 |
流感中和药剂
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
JP2015525794A
(ja)
|
2012-08-06 |
2015-09-07 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
乳児においてrsv及び百日咳菌に対する免疫応答を惹起するための方法
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
JP6302909B2
(ja)
|
2012-08-18 |
2018-03-28 |
アカデミア シニカAcademia Sinica |
シアリダーゼの同定および画像化のための細胞透過性プローブ
|
CA3113959A1
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
RS58700B1
(sr)
|
2012-10-12 |
2019-06-28 |
Broad Inst Inc |
Gsk3 inhibitori i postupci njihove primene
|
US10112927B2
(en)
|
2012-10-18 |
2018-10-30 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
US9758522B2
(en)
|
2012-10-19 |
2017-09-12 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
WO2014063054A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
|
PT2914296T
(pt)
|
2012-11-01 |
2018-10-30 |
Infinity Pharmaceuticals Inc |
Tratamento de cancros utilizando moduladores de isoformas de pi3-quinase
|
US9604919B2
(en)
|
2012-11-01 |
2017-03-28 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
WO2014071247A1
(en)
|
2012-11-02 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
|
MX2015006390A
(es)
|
2012-11-21 |
2015-08-05 |
Topokine Therapeutics Inc |
Metodos y composiciones para incrementar localmente la grasa corporal.
|
JP6408478B2
(ja)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
|
PT2922554T
(pt)
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
US9604930B2
(en)
|
2012-12-21 |
2017-03-28 |
Epizyme, Inc. |
Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
|
CA2894126A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
US8940726B2
(en)
|
2012-12-21 |
2015-01-27 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
WO2014100716A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
JP2016504050A
(ja)
|
2013-01-17 |
2016-02-12 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
細胞表現型の改変のためのシグナルセンサーポリヌクレオチド
|
CA2900008A1
(en)
|
2013-02-07 |
2014-08-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
SG11201505744XA
(en)
|
2013-02-07 |
2015-08-28 |
Massachusetts Inst Technology |
Human adaptation of h5 influenza
|
WO2014159813A1
(en)
|
2013-03-13 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
CN110105434A
(zh)
|
2013-03-13 |
2019-08-09 |
哈佛大学的校长及成员们 |
钉合且缝合的多肽及其用途
|
NZ629037A
(en)
|
2013-03-15 |
2017-04-28 |
Infinity Pharmaceuticals Inc |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
MX2015013894A
(es)
|
2013-04-03 |
2015-12-11 |
Allertein Therapeutics Llc |
Composiciones de nanoparticulas novedosas.
|
CA3130061A1
(en)
|
2013-04-04 |
2014-10-09 |
President And Fellows Of Harvard College |
Macrolides and methods of their preparation and use
|
ES2774330T3
(es)
|
2013-04-09 |
2020-07-20 |
Massachusetts Inst Technology |
Polímero de suministro de fármaco y usos del mismo
|
US10301359B2
(en)
|
2013-04-30 |
2019-05-28 |
Massachusetts Institute Of Technology |
Human adaptation of H3 influenza
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(fi)
|
2013-05-10 |
2018-06-16 |
|
|
KR20160013204A
(ko)
|
2013-05-30 |
2016-02-03 |
인피니티 파마슈티칼스, 인코포레이티드 |
Pi3 키나아제 동형단백질 조절제를 사용하는 암의 치료
|
WO2014197723A2
(en)
|
2013-06-05 |
2014-12-11 |
Massachusetts Institute Of Technology |
Human adaptation of h7 ha
|
CA2914815A1
(en)
|
2013-06-11 |
2014-12-18 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
JP2016523241A
(ja)
|
2013-06-14 |
2016-08-08 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
安定化されたポリペプチドインスリン受容体調節剤
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
CN105611835A
(zh)
|
2013-07-25 |
2016-05-25 |
达纳-法伯癌症研究所股份有限公司 |
转录因子抑制剂及其用途
|
EP3492097A1
(en)
|
2013-08-05 |
2019-06-05 |
GlaxoSmithKline Biologicals S.A. |
Combination immunogenic compositions
|
CA2919383A1
(en)
|
2013-08-05 |
2015-02-12 |
Greenlight Biosciences, Inc. |
Engineered proteins with a protease cleavage site
|
CA2923579C
(en)
|
2013-09-06 |
2023-09-05 |
Academia Sinica |
Human inkt cell activation using glycolipids with altered glycosyl groups
|
EP3092220B1
(en)
|
2013-09-25 |
2021-01-20 |
University of Florida Research Foundation, Inc. |
Vitamin c prodrugs and uses thereof
|
BR112016007467B1
(pt)
|
2013-10-04 |
2022-09-20 |
Infinity Pharmaceuticals, Inc |
Compostos heterocíclicos e usos dos mesmos
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2015057894A1
(en)
|
2013-10-15 |
2015-04-23 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
US9902986B2
(en)
|
2013-10-16 |
2018-02-27 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
WO2015058126A1
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of prolferative diseases
|
JP6491202B2
(ja)
|
2013-10-18 |
2019-03-27 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
サイクリン依存性キナーゼ7(cdk7)の多環阻害剤
|
US20160244452A1
(en)
|
2013-10-21 |
2016-08-25 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
KR20160099084A
(ko)
|
2013-11-01 |
2016-08-19 |
칼라 파마슈티컬스, 인크. |
치료 화합물의 결정질 형태 및 그의 용도
|
US9623194B2
(en)
|
2013-12-10 |
2017-04-18 |
Becton, Dickinson And Company |
Passive safety pen needle assembly
|
ES2863959T3
(es)
|
2013-12-10 |
2021-10-13 |
Becton Dickinson Co |
Conjunto de aguja de bolígrafo de seguridad activa
|
TN2016000240A1
(en)
|
2013-12-24 |
2017-10-06 |
Harvard College |
Cortistatin analogues and syntheses and uses thereof.
|
CA2937123A1
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
AU2015226911B2
(en)
|
2014-03-07 |
2018-03-01 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain
|
CN113620958A
(zh)
|
2014-03-19 |
2021-11-09 |
无限药品股份有限公司 |
用于治疗PI3K-γ介导的障碍的杂环化合物
|
CN106415244B
(zh)
|
2014-03-27 |
2020-04-24 |
中央研究院 |
反应性标记化合物及其用途
|
CN113403338A
(zh)
|
2014-03-28 |
2021-09-17 |
华盛顿大学商业中心 |
乳腺癌和卵巢癌疫苗
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US10039816B2
(en)
|
2014-04-30 |
2018-08-07 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
CN111620940A
(zh)
|
2014-05-21 |
2020-09-04 |
哈佛大学的校长及成员们 |
Ras抑制肽和其用途
|
EP3149036A4
(en)
|
2014-05-27 |
2017-12-27 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
TWI717319B
(zh)
|
2014-05-27 |
2021-02-01 |
中央研究院 |
得自類桿菌屬之岩藻糖苷酶及其用途
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
EP4116329A1
(en)
|
2014-05-27 |
2023-01-11 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
TWI732738B
(zh)
|
2014-05-28 |
2021-07-11 |
中央研究院 |
抗TNF-α醣抗體及其用途
|
MX2016016533A
(es)
|
2014-06-13 |
2017-05-01 |
Glaxosmithkline Biologicals Sa |
Combinaciones inmunogenas.
|
GEP20197011B
(en)
|
2014-06-19 |
2019-08-12 |
Ariad Pharma Inc |
Heteroaryl compounds for kinase inhibition
|
US10188661B2
(en)
|
2014-06-27 |
2019-01-29 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
WO2016004202A1
(en)
|
2014-07-02 |
2016-01-07 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
WO2016011386A1
(en)
|
2014-07-18 |
2016-01-21 |
University Of Washington |
Cancer vaccine compositions and methods of use thereof
|
US10736966B2
(en)
|
2014-08-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Brush-poly (glycoamidoamine)-lipids and uses thereof
|
CA2960712A1
(en)
|
2014-09-08 |
2016-03-17 |
Academia Sinica |
Human inkt cell activation using glycolipids
|
SG11201702175YA
(en)
|
2014-09-24 |
2017-04-27 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and formulations thereof
|
AU2015320549A1
(en)
|
2014-09-24 |
2017-04-13 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
RS60737B1
(sr)
|
2014-10-21 |
2020-09-30 |
Ariad Pharma Inc |
Kristalni oblici 5-hloro-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidin-2,4-diamina
|
WO2016066618A2
(en)
|
2014-10-28 |
2016-05-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for antigen-specific tolerance
|
EP3041948B1
(en)
|
2014-11-10 |
2019-01-09 |
Modernatx, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
US10253045B2
(en)
|
2014-11-26 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
EP3230272B1
(en)
|
2014-12-10 |
2020-08-19 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
|
CN107205938A
(zh)
|
2014-12-18 |
2017-09-26 |
温德加普医疗股份有限公司 |
用于溶解或增溶治疗剂的方法和组合物
|
EP3237066B1
(en)
|
2014-12-23 |
2020-10-21 |
Sloan-Kettering Institute for Cancer Research |
Polymorph of granaticin b
|
AU2015371251B2
(en)
|
2014-12-23 |
2020-06-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
CA2972072A1
(en)
|
2015-01-24 |
2016-07-28 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
BR112017019738A2
(pt)
|
2015-03-20 |
2018-05-29 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos e usos dos mesmos
|
WO2016160617A2
(en)
|
2015-03-27 |
2016-10-06 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
MY193444A
(en)
|
2015-03-30 |
2022-10-13 |
Greenlight Biosciences Inc |
Cell-free production of ribonucleic acid
|
WO2016176343A1
(en)
|
2015-04-27 |
2016-11-03 |
University Of Florida Research Foundation, Incorporated |
Metabolically programmed metal chelators and uses thereof
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
EP3307728A4
(en)
|
2015-06-12 |
2019-07-17 |
Dana Farber Cancer Institute, Inc. |
ASSOCIATION THERAPY USING TRANSCRIPTION INHIBITORS AND KINASE INHIBITORS
|
RS64331B1
(sr)
|
2015-06-19 |
2023-08-31 |
Massachusetts Inst Technology |
Alkenil supstituisani 2,5-piperazindioni i njihova primena u sastavima za isporuku agensa u organizam ili ćeliju subjekta
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
EP3347018B1
(en)
|
2015-09-09 |
2021-09-01 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
EP3347372A4
(en)
|
2015-09-10 |
2019-09-04 |
Aileron Therapeutics, Inc. |
PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1
|
PT3350157T
(pt)
|
2015-09-17 |
2022-03-18 |
Modernatx Inc |
Compostos e composições para administração intracelular de agentes terapêuticos
|
CA2998370A1
(en)
|
2015-09-17 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucleotides containing a stabilizing tail region
|
WO2017059389A1
(en)
|
2015-10-01 |
2017-04-06 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising a statin for use in methods of adipolysis
|
EP3369447A4
(en)
*
|
2015-10-30 |
2019-06-26 |
Terumo Kabushiki Kaisha |
PREHENSION AND SYRINGE ELEMENT ASSEMBLY
|
ES2913626T3
(es)
|
2015-12-22 |
2022-06-03 |
Modernatx Inc |
Compuestos y composiciones para la administración intracelular de agentes
|
USD806246S1
(en)
|
2016-02-25 |
2017-12-26 |
Steven Schraga |
Lancet cover
|
CA3016170A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
BR112018070506A2
(pt)
|
2016-04-06 |
2019-01-29 |
Greenlight Biosciences Inc |
produção isenta de células de ácido ribonucleico
|
BR112018075078A2
(pt)
|
2016-06-03 |
2019-03-06 |
Sanofi Pasteur Inc. |
modificação de polipeptídeos da hemaglutinina do influenza manipulados
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US20200069599A1
(en)
|
2016-06-14 |
2020-03-05 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
CA3031797A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
MX2019001342A
(es)
|
2016-08-05 |
2019-07-04 |
Sanofi Pasteur Inc |
Composicion de conjugado de proteina-polisacarido de neumococo multivalente.
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
US20180085555A1
(en)
*
|
2016-09-26 |
2018-03-29 |
Boston Scientific Scimed, Inc. |
Injection catheter
|
WO2018089540A1
(en)
|
2016-11-08 |
2018-05-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
CN117731591A
(zh)
|
2016-11-21 |
2024-03-22 |
艾里奥治疗公司 |
大试剂的透皮递送
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
AU2018234828A1
(en)
|
2017-03-15 |
2019-09-19 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
ES2940259T3
(es)
|
2017-03-15 |
2023-05-04 |
Modernatx Inc |
Compuesto y composiciones para la administración intracelular de agentes terapéuticos
|
EP3601326A4
(en)
|
2017-03-20 |
2020-12-16 |
The Broad Institute, Inc. |
COMPOUNDS AND METHODS OF REGULATING INSULIN SECRETION
|
CA3058198A1
(en)
|
2017-04-05 |
2018-10-11 |
The Broad Institute, Inc. |
Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
US11744801B2
(en)
|
2017-08-31 |
2023-09-05 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
MX2020003841A
(es)
|
2017-10-11 |
2020-11-06 |
Greenlight Biosciences Inc |
Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos.
|
WO2019109079A1
(en)
|
2017-12-01 |
2019-06-06 |
North Carolina State University |
Fibrin particles and methods of making the same
|
KR20210057140A
(ko)
|
2018-09-13 |
2021-05-20 |
에이리온 테라퓨틱스, 인코포레이티드 |
플라즈미노겐 활성인자 억제제 1 (pai-1) 억제제의 용도
|
MX2021002995A
(es)
|
2018-09-13 |
2021-07-15 |
Eirion Therapeutics Inc |
Inhibidores del inhibidor 1 de activador de plasminogeno (pai-1) y usos de los mismos.
|
US20220409536A1
(en)
|
2018-09-19 |
2022-12-29 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
US20210378980A1
(en)
|
2018-09-20 |
2021-12-09 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
WO2020117564A1
(en)
|
2018-12-03 |
2020-06-11 |
Eirion Therapeutics, Inc. |
Improved delivery of large agents
|
CA3126798A1
(en)
|
2019-01-16 |
2020-07-23 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
CA3126815A1
(en)
|
2019-01-16 |
2020-07-23 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
MX2021009245A
(es)
|
2019-01-31 |
2021-11-12 |
Modernatx Inc |
Metodos de preparacion de nanoparticulas lipidicas.
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
KR20220008311A
(ko)
|
2019-05-14 |
2022-01-20 |
에이리온 테라퓨틱스, 인코포레이티드 |
최대 효과 지연 및/또는 반응 지속시간 연장
|
CN110236781B
(zh)
*
|
2019-06-13 |
2021-06-29 |
南京医科大学眼科医院 |
一次性无菌可调节用治疗针
|
CA3149386A1
(en)
|
2019-07-31 |
2021-02-04 |
Modernatx, Inc. |
Compositions and methods for delivery of rna interference agents to immune cells
|
BR112022001654A2
(pt)
|
2019-07-31 |
2022-07-12 |
Sanofi Pasteur Inc |
Composições conjugadas de proteinas de polissacarídeos pneumocócicos multivalentes e métodos de utilização dos mesmos
|
AU2020384885A1
(en)
|
2019-11-13 |
2022-06-09 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
BR112022014970A2
(pt)
|
2020-01-31 |
2022-09-20 |
Modernatx Inc |
Métodos para preparar nanopartículas lipídicas
|
US11642407B2
(en)
|
2020-02-28 |
2023-05-09 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
US20230390296A1
(en)
|
2020-10-30 |
2023-12-07 |
Keio University |
Novel treatment and prevention of sarcopenia-related diseases
|
JPWO2022092295A1
(fi)
|
2020-10-30 |
2022-05-05 |
|
|
TW202237068A
(zh)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
製備脂質奈米顆粒的高通量方法及其用途
|
WO2022192176A1
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
TW202333778A
(zh)
|
2021-10-08 |
2023-09-01 |
美商賽諾菲巴斯德公司 |
多價流感疫苗
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
TW202333654A
(zh)
|
2021-12-16 |
2023-09-01 |
美商現代公司 |
用於製備脂質奈米顆粒之方法
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023172592A1
(en)
*
|
2022-03-11 |
2023-09-14 |
Amgen Inc. |
Adjustable depth autoinjector
|
WO2023177577A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|